810.24
price up icon0.53%   4.31
after-market Dopo l'orario di chiusura: 810.50 0.26 +0.03%
loading
Precedente Chiudi:
$805.93
Aprire:
$814
Volume 24 ore:
614.85K
Relative Volume:
0.64
Capitalizzazione di mercato:
$83.42B
Reddito:
$14.92B
Utile/perdita netta:
$4.42B
Rapporto P/E:
19.74
EPS:
41.0422
Flusso di cassa netto:
$3.79B
1 W Prestazione:
+1.66%
1M Prestazione:
+19.74%
6M Prestazione:
+2.28%
1 anno Prestazione:
+41.18%
Intervallo 1D:
Value
$805.93
$821.02
Intervallo di 1 settimana:
Value
$784.61
$821.02
Portata 52W:
Value
$541.00
$821.11

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
Nome
Regeneron Pharmaceuticals Inc
Name
Telefono
(914) 847-7000
Name
Indirizzo
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Name
Dipendente
15,410
Name
Cinguettio
@regeneron
Name
Prossima data di guadagno
2026-07-30
Name
Ultimi documenti SEC
Name
REGN's Discussions on Twitter

Compare REGN vs VRTX, ARGX, RVMD, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
REGN icon
REGN
Regeneron Pharmaceuticals Inc
810.24 82.97B 14.92B 4.42B 3.79B 41.04
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
528.19 130.67B 12.34B 4.34B 3.71B 16.87
ARGX icon
ARGX
Argen X Se Adr
992.99 61.80B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
216.00 45.44B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
369.15 41.01B 5.76B 514.49M 1.10B 4.4813

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-03-31 Ripresa Piper Sandler Overweight
2026-03-06 Iniziato Barclays Overweight
2026-01-07 Aggiornamento BofA Securities Underperform → Buy
2025-12-03 Downgrade Morgan Stanley Overweight → Equal-Weight
2025-11-24 Iniziato HSBC Securities Buy
2025-11-24 Ripresa Truist Buy
2025-11-13 Iniziato Scotiabank Sector Perform
2025-08-14 Iniziato Rothschild & Co Redburn Buy
2025-06-30 Downgrade Argus Buy → Hold
2025-05-30 Downgrade RBC Capital Mkts Outperform → Sector Perform
2025-05-30 Downgrade Wells Fargo Overweight → Equal Weight
2025-05-14 Aggiornamento Citigroup Neutral → Buy
2025-04-22 Ripresa Cantor Fitzgerald Overweight
2025-02-05 Aggiornamento Leerink Partners Market Perform → Outperform
2025-01-16 Downgrade UBS Buy → Neutral
2024-12-10 Ripresa BofA Securities Underperform
2024-11-15 Iniziato Wolfe Research Outperform
2024-11-14 Iniziato Citigroup Neutral
2024-09-24 Downgrade Leerink Partners Outperform → Market Perform
2024-03-12 Iniziato Bernstein Outperform
2024-01-12 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Iniziato Deutsche Bank Hold
2023-11-03 Aggiornamento Raymond James Mkt Perform → Outperform
2023-08-21 Aggiornamento Canaccord Genuity Hold → Buy
2023-08-21 Reiterato Oppenheimer Perform
2023-06-28 Downgrade Canaccord Genuity Buy → Hold
2023-03-27 Aggiornamento SVB Securities Market Perform → Outperform
2023-03-24 Aggiornamento Jefferies Hold → Buy
2023-03-23 Aggiornamento Raymond James Underperform → Mkt Perform
2023-01-30 Aggiornamento Cowen Market Perform → Outperform
2023-01-20 Aggiornamento JP Morgan Neutral → Overweight
2022-10-26 Downgrade Raymond James Mkt Perform → Underperform
2022-10-17 Downgrade Evercore ISI Outperform → In-line
2022-09-09 Aggiornamento Jefferies Underperform → Hold
2022-09-09 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-07-25 Downgrade SVB Leerink Outperform → Mkt Perform
2022-07-13 Iniziato Cantor Fitzgerald Neutral
2022-06-06 Iniziato Jefferies Underperform
2022-05-23 Iniziato SVB Leerink Outperform
2022-01-05 Downgrade BofA Securities Neutral → Underperform
2022-01-03 Aggiornamento Bernstein Mkt Perform → Outperform
2021-12-15 Downgrade Bernstein Outperform → Mkt Perform
2021-12-09 Ripresa Wells Fargo Overweight
2021-12-07 Ripresa Cowen Market Perform
2021-12-06 Iniziato Goldman Buy
2021-11-19 Ripresa BMO Capital Markets Outperform
2021-11-05 Downgrade The Benchmark Company Buy → Hold
2021-06-29 Iniziato H.C. Wainwright Buy
2021-01-25 Aggiornamento BMO Capital Markets Market Perform → Outperform
2021-01-13 Aggiornamento The Benchmark Company Hold → Buy
2021-01-08 Aggiornamento Citigroup Neutral → Buy
2020-10-05 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2020-08-20 Downgrade The Benchmark Company Buy → Hold
2020-07-09 Aggiornamento SunTrust Hold → Buy
2020-05-26 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-04-28 Downgrade Citigroup Buy → Neutral
2020-04-17 Aggiornamento The Benchmark Company Hold → Buy
2020-04-08 Iniziato The Benchmark Company Hold
2020-03-31 Iniziato Wolfe Research Peer Perform
2020-02-27 Iniziato Barclays Overweight
2020-02-26 Aggiornamento Canaccord Genuity Hold → Buy
2020-02-26 Downgrade Robert W. Baird Outperform → Neutral
2020-02-25 Aggiornamento Jefferies Hold → Buy
2020-02-11 Aggiornamento Argus Hold → Buy
2019-12-24 Iniziato Raymond James Mkt Perform
2019-12-16 Downgrade Evercore ISI Outperform → In-line
2019-12-13 Aggiornamento Credit Suisse Neutral → Outperform
2019-11-12 Iniziato SunTrust Hold
2019-11-07 Aggiornamento Citigroup Neutral → Buy
2019-10-17 Ripresa BofA/Merrill Neutral
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
Mostra tutto

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

pulisher
12:05 PM

Promising Biotech Stocks To Watch TodayAugust 18th - MarketBeat

12:05 PM
pulisher
10:11 AM

REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - PR Newswire

10:11 AM
pulisher
09:58 AM

Regeneron ends eye disease study due to antibody’s safety profile - BioSpace

09:58 AM
pulisher
09:18 AM

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - TMX Newsfile

09:18 AM
pulisher
07:28 AM

Regeneron ends eye disease study after antibody shows ‘unfavorable’ risk/benefit profile - BioSpace

07:28 AM
pulisher
07:21 AM

REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

07:21 AM
pulisher
06:54 AM

Resilient Regeneron stock trades close to 52-week high as dividend and earnings support valuation - AD HOC NEWS

06:54 AM
pulisher
06:28 AM

UNIVEST FINANCIAL Corp Takes $8.15 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

06:28 AM
pulisher
06:23 AM

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action LawsuitHagens Berman Sobol Shapiro LLP - PR Newswire

06:23 AM
pulisher
06:06 AM

Perigon Wealth Management LLC Takes Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

06:06 AM
pulisher
06:00 AM

Mitsubishi UFJ Asset Management Co. Ltd. Invests $160.53 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

06:00 AM
pulisher
05:19 AM

Regeneron halts early-stage uveitis trial after safety event - The Pharma Letter

05:19 AM
pulisher
04:36 AM

4,376 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by Citizens Financial Group Inc. RI - MarketBeat

04:36 AM
pulisher
04:32 AM

Deutsche Bank AG Makes New $323.25 Million Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

04:32 AM
pulisher
04:32 AM

Grandfield & Dodd LLC Purchases Shares of 36,628 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

04:32 AM
pulisher
03:27 AM

BlackRock Inc. Makes New $5.68 Billion Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

03:27 AM
pulisher
03:27 AM

4,778 Shares in Regeneron Pharmaceuticals, Inc. $REGN Bought by B & T Capital Management DBA Alpha Capital Management - MarketBeat

03:27 AM
pulisher
Aug 17, 2026

Samsung Biologics? No — Samchundang Pharm Reaches Landmark Settlement in Eylea Biosimilar Patent Dispute, Clearing Path for Global Commercialization - finance.biggo.com

Aug 17, 2026
pulisher
Aug 17, 2026

Regeneron Pharmaceuticals, Inc. Notice of September 14, - globenewswire.com

Aug 17, 2026
pulisher
Aug 17, 2026

Resilient Regeneron stock hovers near 52-week high after dividend and analyst target hike - AD HOC NEWS

Aug 17, 2026
pulisher
Aug 17, 2026

REGN UPCOMING DEADLINE: Levi & Korsinsky Alerts Regeneron - GlobeNewswire

Aug 17, 2026
pulisher
Aug 17, 2026

Biotech Stocks To ResearchAugust 17th - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Can Regeneron Pharmaceuticals (NASDAQ:REGN) Extend Its Run? - Kalkine Media

Aug 17, 2026
pulisher
Aug 17, 2026

REGN Investors Have Opportunity to Lead Regeneron - GlobeNewswire

Aug 17, 2026
pulisher
Aug 17, 2026

REGN Maintained by Leerink Partners -- Price Target Raised to $8 - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $824.00 at Leerink Partners - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Leerink Partners Adjusts PT on Regeneron Pharmaceuticals to $824 From $641, Maintains Market Perform Rating - marketscreener.com

Aug 17, 2026
pulisher
Aug 17, 2026

Plato Investment Management Ltd Makes New $2.47 Million Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Oppenheimer Asset Management Inc. Takes $1.50 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Focus Partners Advisor Solutions LLC Invests $1.35 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

AMG National Trust Bank Makes New $1.22 Million Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 17, 2026
pulisher
Aug 16, 2026

Bronstein, Gewirtz & Grossman LLC Urges Regeneron - GlobeNewswire

Aug 16, 2026
pulisher
Aug 16, 2026

REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Aug 16, 2026
pulisher
Aug 16, 2026

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 16, 2026
pulisher
Aug 15, 2026

ETFs Investing in Regeneron Pharmaceuticals, Inc. Stocks - TradingView

Aug 15, 2026
pulisher
Aug 15, 2026

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments - MarketBeat

Aug 15, 2026
pulisher
Aug 15, 2026

How Securities Lawsuits Over Trial Disclosures Will Impact Regeneron Pharmaceuticals’ (REGN) Pipeline-Driven Investment Story - simplywall.st

Aug 15, 2026
pulisher
Aug 15, 2026

Wall Street Zen Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Strong-Buy - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aug 14, 2026
pulisher
Aug 14, 2026

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk) - fool.com

Aug 14, 2026
pulisher
Aug 14, 2026

Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline? - finance.yahoo.com

Aug 14, 2026
pulisher
Aug 14, 2026

Bernstein Lifts Regeneron Price Target to $756, Stays on Sidelines - finance.biggo.com

Aug 14, 2026
pulisher
Aug 14, 2026

If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today - Benzinga

Aug 14, 2026
pulisher
Aug 14, 2026

Regeneron Genetics Center's Andy Deubler: The AI-Era Genomics Race Will Be Decided by Curation, Not Volume - finance.biggo.com

Aug 14, 2026
pulisher
Aug 14, 2026

The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class ... - Caledonian Record

Aug 14, 2026
pulisher
Aug 14, 2026

Bernstein raises Regeneron stock price target to $756 on Eylea beat - Investing.com

Aug 14, 2026
pulisher
Aug 14, 2026

BMS builds big in Texas; Regeneron backs would-be rival - Pharma Voice

Aug 14, 2026
pulisher
Aug 14, 2026

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Regeneron's Gene Therapy For Genetic Hearing Loss Gets Accelerated FDA Nod — Drug Pricing Deal With White House To Be Announced Today - Stocktwits

Aug 14, 2026
pulisher
Aug 13, 2026

REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aug 13, 2026
pulisher
Aug 13, 2026

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 13, 2026

Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Regeneron Pharmaceuticals Inc Azioni (REGN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Guarini Kathryn
Director
Aug 10 '26
Sale
800.00
400
320,000
603
Zoghbi Huda Y
Director
Aug 10 '26
Option Exercise
376.69
800
301,352
2,503
Zoghbi Huda Y
Director
Aug 10 '26
Sale
800.00
800
640,000
1,703
$992.99
price up icon 0.52%
$216.00
price up icon 1.89%
ONC ONC
$369.15
price up icon 1.83%
$528.19
price up icon 2.45%
$228.61
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):